Publications by authors named "P Moleman"

Claim this Profile
D
Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial.
Jan P A M Bogers, Peter F J Schulte, Theo G Broekman, Peter Moleman, Lieuwe de Haan

Eur Neuropsychopharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reaction on 'Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines'].
P Moleman

Tijdschr Psychiatr· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of imipramine in psychotic versus nonpsychotic depression.
Tom K Birkenhager, Walter W van den Broek, Paul G Mulder, Peter Moleman, Jan A Bruijn

J Clin Psychopharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Tom K Birkenhäger, Walter W van den Broek, Durk Fekkes, Paul G Mulder, Peter Moleman

Prog Neuropsychopharmacol Biol Psychiatry· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-dependent clearance decrements of fluvoxamine in depressed inpatients: a clinical evaluation.
Walter W van den Broek, Tom K Birkenhäger, Paul G H Mulder, Ron A A Mathot, Jan A Bruijn, Peter Moleman

J Clin Psychopharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis